Xueying Li
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 12, 2023
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial.Mixue Xie, Ying Lu, Guifang Ouyang
|Feb 15, 2023
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial.De Zhou, Xianbo Huang, Mixue Xie
|Mar 25, 2021
Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia.Huanping Wang, Yile Zhou, Xin Huang
|Dec 11, 2020
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.Huan-Ping Wang, Yi-Le Zhou, Xin Huang
|Nov 18, 2020
Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era.Ting Shi, Huanping Wang, Mixue Xie
|Apr 22, 2020
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.Xue-Ying Li, Jie-Jing Qian, Min Yang
Pageof 1
